Ivabradine improves coronary flow reserve in patients with stable coronary artery disease

Atherosclerosis

Volumn 215, Issue 1, 2011, Pages 160-165

  Skalidis, Emmanouil I ^a   Hamilos, Michalis I ^a   Chlouverakis, Gregory ^b   Zacharis, Evangelos A ^a   Vardas, Panos E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Coronary artery disease; Coronary blood flow; Ivabradine; Microcirculation

Indexed keywords

ADENOSINE; GLYCERYL TRINITRATE; IVABRADINE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERIAL PRESSURE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY SPASM; CORONARY BLOOD VESSEL; CORONARY FLOW RESERVE; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; FEMALE; GUIDE WIRE; HEART PACING; HEART RATE; HUMAN; HYPEREMIA; MALE; PRIORITY JOURNAL;

AGED; BENZAZEPINES; BLOOD FLOW VELOCITY; CORONARY ARTERY DISEASE; CORONARY CIRCULATION; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED;

EID: 79952100547     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2010.11.035     Document Type: Article

References (27)

1. Diaz A., Bourassa M.G., Guertin M.C., et al. Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J 2005, 26:967-974.
2. Fox K., Ford I., Steg P.G., et al. Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 2008, 372:817-821.
3. Fox K., Ford I., Steg P.G., et al. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:807-816.
4. Britten M.B., Zeiher A.M., Schächinger V. Microvascular dysfunction in angiographically normal or mildly diseased coronary arteries predicts adverse cardiovascular long-term outcome. Coron Artery Dis 2004, 15:259-264.
5. Herzog B.A., Husmann L., Valenta I., et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 2009, 54:150-156.
6. Pijls N.H., van Schaardenburgh P., Manoharan G., et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol 2007, 49:2105-2111.
7. Tonino P.A., De Bruyne B., Pijls N.H., et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009, 360:213-224.
8. Gould K.L. Pressure-flow characteristics of coronary stenoses in unsedated dogs at rest and during coronary vasodilation. Circ Res 1978, 43:242-253.
9. Skalidis E.I., Kochiadakis G.E., Koukouraki S.I., et al. Phasic coronary flow pattern and flow reserve in patients with left bundle branch block and normal coronary arteries. J Am Coll Cardiol 1999, 33:1338-1346.
10. Rossen J.D., Winniford M.D. Effect of increases in heart rate and arterial pressure on coronary flow reserve in humans. J Am Coll Cardiol 1993, 21:343-348.
11. Accili E.A., Proenza C., Baruscotti M., et al. From funny current to HCN channels: 20 years of excitation. News Physiol Sci 2002, 17:32-37.
12. Ludwig A., Zong X., Jeglitsch M., et al. A family of hyperpolarization-activated mammalian cation channels. Nature 1998, 393:587-591.
13. Shi W., Wymore R., Yu H., et al. Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues. Circ Res 1999, 85:e1-e6.
14. Ceconi C., Cargnoni A., Francolini G., et al. Heart rate reduction with ivabradine improves energy metabolism and mechanical function of isolated ischaemic rabbit heart. Cardiovasc Res 2009, 84:72-82.
15. Gewirtz H. 'Funny' current: if heart rate slowing is not the best answer, what might be?. Cardiovasc Res 2009, 84:9-10.
16. Heusch G., Skyschally A., Gres P., et al. Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction. Eur Heart J 2008, 29:2265-2275.
17. Fox K., Ford I., Steg P.G., et al. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial. Eur Heart J 2009, 30:2337-2345.
18. Heusch G. A BEAUTIFUL lesson-ivabradine protects from ischaemia, but not from heart failure: through heart rate reduction or more?. Eur Heart J 2009, 30:2300-2301.
19. Heusch G. Pleiotropic action(s) of the bradycardic agent ivabradine: cardiovascular protection beyond heart rate reduction. Br J Pharmacol 2008, 155:970-971.
20. Davies J.E., Whinnett Z.I., Francis D.P., et al. Evidence of a dominant backward-propagating " suction" wave responsible for diastolic coronary filling in humans, attenuated in left ventricular hypertrophy. Circulation 2006, 113:1768-1778.
21. Billinger M., Seiler C., Fleisch M., et al. Do beta-adrenergic blocking agents increase coronary flow reserve?. J Am Coll Cardiol 2001, 38:1866-1871.
22. Togni M., Vigorito F., Windecker S., et al. Does the beta-blocker nebivolol increase coronary flow reserve?. Cardiovasc Drugs Ther 2007, 21:99-108.
23. Skalidis E.I., Hamilos M.I., Chlouverakis G., et al. Acute effect of esmolol intravenously on coronary microcirculation in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2007, 100:1299-1302.
24. Wilson R.F., Laughlin D.E., Ackell P.H., et al. Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man. Circulation 1985, 72:82-92.
25. Doucette J.W., Corl P.D., Payne H.M., et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992, 85:1899-1911.
26. Kaufmann P.A., Gnecchi-Ruscone T., Yap J.T., et al. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET. J Nucl Med 1999, 40:1848-1856.
27. Jagathesan R., Kaufmann P.A., Rosen S.D., et al. Assessment of the long-term reproducibility of baseline and dobutamine-induced myocardial blood flow in patients with stable coronary artery disease. J Nucl Med 2005, 46:212-219.